Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3070797 | Neurobiology of Disease | 2007 | 8 Pages |
Abstract
We examined the effect of triamcinolone acetonide (TA), a corticosteroid, on the relationship between vascular pathophysiology and vascular endothelial growth factor (VEGF) activation in the retina of a rat model of oxygen-induced retinopathy (OIR). OIR was induced by exposure of hyperoxia (80% oxygen) to Sprague-Dawley (SD) rats from P2 to P14 and then returned to normoxic conditions. TA was intravitreal-injected once into the right eye of OIR rats at P15. Effects of TA on vascular pathophysiology or changes of various genes in response to hypoxia and/or proinflammation under hypoxic retina were assessed by the Evans-blue method, fluorescein isothiocyanate-dextran (FITC-D) infusion, immunoblotting, and ELIZA. TA not only reduced retinal neovascularization and vascular leakage in the OIR-rat retina, but also blocked the induction of hypoxia-response proinflammatory genes before it negatively controlled VEGF activation. These findings suggest a potential that TA suppresses retinal neovascular pathophysiology via proinflammation-mediated activation of VEGF during hypoxia.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Y.H. Kim, I.Y. Chung, M.Y. Choi, Y.S. Kim, J.H. Lee, C.H. Park, S.S. Kang, G.S. Roh, W.S. Choi, J.M. Yoo, G.J. Cho,